SlideShare ist ein Scribd-Unternehmen logo
1 von 47
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL

Weitere ähnliche Inhalte

Was ist angesagt?

Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
i3 Health
 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprint
fondas vakalis
 

Was ist angesagt? (20)

Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...
Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...
Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...
 
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Establish...
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Establish...The Power and Promise of Immunotherapy in Head and Neck Cancer: How Establish...
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Establish...
 
cancer associated thrombocytopenia.pptx
cancer associated thrombocytopenia.pptxcancer associated thrombocytopenia.pptx
cancer associated thrombocytopenia.pptx
 
Lorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancerLorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancer
 
mHSPC Feb 2023.pptx
mHSPC Feb 2023.pptxmHSPC Feb 2023.pptx
mHSPC Feb 2023.pptx
 
Update in tnbc
Update in tnbcUpdate in tnbc
Update in tnbc
 
Targeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancerTargeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancer
 
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
 
Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
 
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy...
 
Welcome Basic Principles of Cancer Management
Welcome Basic Principles of Cancer ManagementWelcome Basic Principles of Cancer Management
Welcome Basic Principles of Cancer Management
 
NIH Presentation Nov 2016 Neuroendocrine Tumor Clinical Trials
NIH Presentation Nov 2016 Neuroendocrine Tumor Clinical TrialsNIH Presentation Nov 2016 Neuroendocrine Tumor Clinical Trials
NIH Presentation Nov 2016 Neuroendocrine Tumor Clinical Trials
 
Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)
Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)
Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)
 
New Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial CarcinomaNew Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial Carcinoma
 
Advances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancerAdvances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancer
 
Carcinoma of unknown primary devnani
Carcinoma of unknown primary devnaniCarcinoma of unknown primary devnani
Carcinoma of unknown primary devnani
 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprint
 
Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immu...
Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immu...Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immu...
Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immu...
 
Oncotype dx presentation
Oncotype dx presentationOncotype dx presentation
Oncotype dx presentation
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancer
 

Mehr von PVI, PeerView Institute for Medical Education

Mehr von PVI, PeerView Institute for Medical Education (20)

Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
 
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
 
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
 
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
 
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
 
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
 
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
 
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
 
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
 
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
 
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
 
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
 

Kürzlich hochgeladen

ANATOMIE SYSTEME DIGESTIF AI1354789.pdf
ANATOMIE  SYSTEME DIGESTIF AI1354789.pdfANATOMIE  SYSTEME DIGESTIF AI1354789.pdf
ANATOMIE SYSTEME DIGESTIF AI1354789.pdf
MadickNDAO1
 

Kürzlich hochgeladen (10)

Les tumeurs malignes des glandes salivaires'.pptx
Les tumeurs malignes des glandes salivaires'.pptxLes tumeurs malignes des glandes salivaires'.pptx
Les tumeurs malignes des glandes salivaires'.pptx
 
Histologie du Tube Digestif (Chapitre 2/3 de l'Histologie du l'appareil diges...
Histologie du Tube Digestif (Chapitre 2/3 de l'Histologie du l'appareil diges...Histologie du Tube Digestif (Chapitre 2/3 de l'Histologie du l'appareil diges...
Histologie du Tube Digestif (Chapitre 2/3 de l'Histologie du l'appareil diges...
 
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
 
Les aménorrhée primaire et secondaire .ppt
Les aménorrhée primaire et secondaire .pptLes aménorrhée primaire et secondaire .ppt
Les aménorrhée primaire et secondaire .ppt
 
ANATOMIE SYSTEME DIGESTIF AI1354789.pdf
ANATOMIE  SYSTEME DIGESTIF AI1354789.pdfANATOMIE  SYSTEME DIGESTIF AI1354789.pdf
ANATOMIE SYSTEME DIGESTIF AI1354789.pdf
 
INTRODUCTION GENERALE A LA PARASITOLOGIE.pptx
INTRODUCTION GENERALE  A LA PARASITOLOGIE.pptxINTRODUCTION GENERALE  A LA PARASITOLOGIE.pptx
INTRODUCTION GENERALE A LA PARASITOLOGIE.pptx
 
Amibiase Cours diagnostic biologique .pptx
Amibiase Cours diagnostic biologique .pptxAmibiase Cours diagnostic biologique .pptx
Amibiase Cours diagnostic biologique .pptx
 
antalgique cours 3 année faculté .pptx
antalgique cours 3 année  faculté  .pptxantalgique cours 3 année  faculté  .pptx
antalgique cours 3 année faculté .pptx
 
physologie de la croissance : age osseux.pptx
physologie de la croissance : age osseux.pptxphysologie de la croissance : age osseux.pptx
physologie de la croissance : age osseux.pptx
 
présentation PowerPoint sur les technique d'anesthésie en neurochirurgie.ppt
présentation PowerPoint sur les technique d'anesthésie en neurochirurgie.pptprésentation PowerPoint sur les technique d'anesthésie en neurochirurgie.ppt
présentation PowerPoint sur les technique d'anesthésie en neurochirurgie.ppt